- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Soligenix Inc (SNGX)
Assess today's live Soligenix Inc (SNGX) share price, performance and insights using our live NASDAQ: SNGX stock exchange data.
Analyse the historical data and Soligenix Inc share price performance charts on this page. Our technical summary section provides analysis on Soligenix Inc share price buy/sell indicators using real-time data (or discuss the Soligenix Inc (SNGX) stock price today with other investors in the Soligenix Inc NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SNGX share price (ISIN: US8342236044) to enhance your trading decisions with our free investment tools and resources.
What Is the Soligenix Inc Share Price Today?
The Soligenix Inc share price today is 1.3700.
What Is the Stock Symbol for Soligenix Inc
The stock symbol (or 'ticker') for Soligenix Inc is "SNGX."
What Stock Exchange Does Soligenix Inc Trade On?
Soligenix Inc is listed and trades on the NASDAQ stock exchange.
Is Soligenix Inc a Good Stock to Buy?
Determining whether Soligenix Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Soligenix Inc share price performance charts on this page. Our technical summary section provides analysis on Soligenix Inc share price buy/sell indicators using real-time data (or discuss the Soligenix Inc (SNGX) stock price today with other investors in the Soligenix Inc NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SNGX share price (ISIN: US8342236044) to enhance your trading decisions with our free investment tools and resources.
What Is the Soligenix Inc Share Price Today?
The Soligenix Inc share price today is 1.3700.
What Is the Stock Symbol for Soligenix Inc
The stock symbol (or 'ticker') for Soligenix Inc is "SNGX."
What Stock Exchange Does Soligenix Inc Trade On?
Soligenix Inc is listed and trades on the NASDAQ stock exchange.
Is Soligenix Inc a Good Stock to Buy?
Determining whether Soligenix Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.3100
1.4100
52 wk Range
1.0900
6.2299
SNGX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.31001.4100
52 wk Range
1.09006.2299
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SNGX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
17.5000
Upside
+1,177.37%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral
Soligenix Inc Company Profile
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. It operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator (IDR) technology that is in Phase 3 clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer; SGX945, an IDR technology that is in Phase 2a study to treat aphthous ulcers in Behçet’s disease; and SGX302, an IDR technology, which is in Phase 2a study for the treatment of mild-to-moderate psoriasis. Its Public Health Solutions segment engages in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase 1a, 1b, and 1c clinical trials; SGX943, a therapeutic candidate in preclinical studies for the treatment of antibiotic-resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; CiVax, a vaccine candidate for the prevention of COVID-19; and vaccine programs that target filoviruses, such as Marburg and Ebola. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in September 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.
Compare SNGX to Peers and Sector
Metrics to compare | SNGX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSNGXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.2x | −2.3x | −0.6x | |
PEG Ratio | −0.03 | −0.02 | 0.00 | |
Price/Book | 1.8x | 2.4x | 2.6x | |
Price / LTM Sales | - | 197.8x | 3.2x | |
Upside (Analyst Target) | - | 265.2% | 41.8% | |
Fair Value Upside | Unlock | −4.5% | 5.1% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 17.5000
(+1,177.37% Upside)
Earnings
Latest Release
Nov 07, 2025
EPS / Forecast
-0.58 / -0.12
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Soligenix Inc (SNGX) Share Price Today?
The live Soligenix Inc share price today is 1.3700
What Stock Exchange Does Soligenix Inc (SNGX) Trade On?
Soligenix Inc is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Soligenix Inc?
The stock symbol (also called a 'ticker') for Soligenix Inc is "SNGX."
What Is the Current Soligenix Inc Market Cap?
As of today, Soligenix Inc market capitalisation is 13.82M.
What Is Soligenix Inc's (SNGX) Earnings Per Share (TTM)?
The Soligenix Inc EPS is currently -3.39 (Trailing Twelve Months).
Is SNGX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Soligenix Inc moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Soligenix Inc Stock Split?
Soligenix Inc has split 5 times. (See the SNGX stock split history page for full effective split date and price information.)
How Many Employees Does Soligenix Inc Have?
Soligenix Inc has 15 employees.
What is the current trading status of Soligenix Inc (SNGX)?
As of 24 Dec 2025, Soligenix Inc (SNGX) is trading at a price of 1.3700, with a previous close of 1.3300. The stock has fluctuated within a day range of 1.3100 to 1.4100, while its 52-week range spans from 1.0900 to 6.2299.
What Is Soligenix Inc (SNGX) Price Target According to Analysts?
The average 12-month price target for Soligenix Inc is USD17.5, with a high estimate of USD25 and a low estimate of USD10. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,177.37% Upside potential.
What Is the SNGX Premarket Price?
SNGX's last pre-market stock price is 1.3100. The pre-market share volume is 12,730.0000, and the stock has decreased by -0.0200, or -1.5000%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.